Microalbuminuria in Chronic Obstructive Pulmonary Disease with and Without Co-morbidities
Letter to the Editor
First Online:
- 9 Downloads
Notes
Funding
Financial support by Dept. of Biochemistry, AIIMS Jodhpur; Dr. Purvi Purohit, Associate professor, Dept. of Biochemistry, AIIMS Jodhpur).
References
- 1.Siva KK, Gayathri AR. Prevalence of comorbid conditions in patients of chronic obstructive pulmonary disease (COPD) with acute exacerbation. IJSR. 2015;4(2):1847–50.Google Scholar
- 2.Anthonisen NR, Connett JE, Enright PL, Manfreda J. Lung Health Study Research Group. Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med. 2002;166(3):333–9.CrossRefGoogle Scholar
- 3.Sin DD, Man SF. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc. 2005;2(1):8–11.CrossRefGoogle Scholar
- 4.Celli BD, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–12.CrossRefGoogle Scholar
- 5.Kistorp C, Raymond I, Pedersen F, Gustaffson F, Faber J, Hildebrandt P. N-terminal pro-brain natriuretic peptide C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA. 2005;293:1609–16.CrossRefGoogle Scholar
Copyright information
© Association of Clinical Biochemists of India 2019